SCHEMBL3395307

SCHEMBL3395307

O=CCc1cccc(OC(F)F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 2/20 0.51
MEP1B Q16820 1/20 0.51
DAO P14920 2/20 0.50
MRGPRX4 Q96LA9 1/20 0.46
ALKBH1 Q13686 1/20 0.43
PPARG P37231 2/20 0.42
PPARA Q07869 2/20 0.42
HCRTR1 O43613 2/20 0.41
HCRTR2 O43614 2/20 0.41
MPO P05164 1/20 0.40
NLRP3 Q96P20 1/20 0.40
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1568367 0.85 DAO (0.53) DRD1MEP1BDAOMRGPRX4ALKBH1
SCHEMBL1417171 0.82 P2RX3 (0.47) HCRTR1HCRTR2MEN1KMT2A
SCHEMBL1776056 0.81 MEP1B (0.54) DRD1MEP1BDAOMRGPRX4ALKBH1
SCHEMBL11740538 0.81 DRD1 (0.42) DRD1DAOMRGPRX4PPARGPPARA
SCHEMBL1035570 0.79 CHRM2 (0.58) DAOROCK2ROCK1CHRM2CHRM1
SCHEMBL394184 0.78 MEP1B (0.57) DRD1MEP1BDAOMRGPRX4ALKBH1
SCHEMBL2539937 0.78 MEP1B (0.50) DRD1MEP1BDAOMRGPRX4ALKBH1
SCHEMBL10913301 0.78 MEP1B (0.50) DRD1MEP1BDAOMRGPRX4ALKBH1
SCHEMBL297093 0.78 MEP1B (0.50) DRD1MEP1BDAOMRGPRX4HCRTR1
SCHEMBL1776057 0.78 MEP1B (0.54) DRD1MEP1BDAOMRGPRX4ALKBH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3759098-A1 PYRIDINE-SULFONAMIDE COMPOUNDS AND THEIR USE AGAINST PAIN AND RELATED CONDITIONS Genentech, Inc. (US) 2021-01-06 EP disclosed
WO-2019165290-A1 PYRIDINE-SULFONAMIDE COMPOUNDS AND THEIR USE AGAINST PAIN AND RELATED CONDITIONS GENENTECH, INC. (US) 2019-08-29 WO disclosed
EP-2885306-A1 IMIDAZO[2,1]THIAZOL-3-ONE DERIVATIVES USEFUL AS DIAGNOSTIC AGENTS FOR ALZHEIMER'S DISEASE F. Hoffmann-La Roche AG (CH) 2015-06-24 EP disclosed
WO-2014026881-A1 IMIDAZO[2,1]THIAZOL-3-ONE DERIVATIVES USEFUL AS DIAGNOSTIC AGENTS FOR ALZHEIMER'S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2014-02-20 WO disclosed
EP-2245019-A1 4, 5-DIHYDRO-OXAZOL-2-YL AMINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2010-11-03 EP disclosed
WO-2009103626-A1 4, 5-DIHYDRO-OXAZOL-2-YL AMINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-08-27 WO disclosed
EP-1358169-A2 DIAMINOTHIAZOLES AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASE F. HOFFMANN-LA ROCHE AG (CH) 2003-11-05 EP disclosed
WO-2002057261-A2 DIAMINOTHIAZOLES AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASE F. HOFFMANN-LA ROCHE AG (CH) 2002-07-25 WO disclosed